Laura A. Lane
Corporate Officer/Principal bei ELI LILLY AND COMPANY
Profil
Laura A.
Lane was the founder of Virion Biotherapeutics Ltd.
which was founded in 2015, where she held the title of Chief Operating Officer & Director from 2015 to 2018.
Currently, she is a Vice President at Eli Lilly & Co. since 2022.
Previously, she worked as a Principal at Advent Venture Partners LLP from 2019 to 2022.
Ms. Lane received her undergraduate and doctorate degrees from the University of Cambridge.
Aktive Positionen von Laura A. Lane
Unternehmen | Position | Beginn |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.08.2022 |
Ehemalige bekannte Positionen von Laura A. Lane
Unternehmen | Position | Ende |
---|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private-Equity-Analyst | 01.10.2021 |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Gründer | 30.06.2018 |
Ausbildung von Laura A. Lane
University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 2 |
---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |